RIP2 is a Raf1-activated mitogen-activated protein kinase kinase

Area of Science:

• Molecular Biology
• Cell Signaling
• Signal Transduction

Background:

• Receptor-interacting protein 2 (RIP2) is a serine-threonine kinase linked to the tumor necrosis factor (TNF) receptor complex.
• RIP2 is involved in NF-kappaB activation and cell death, but the role of its kinase domain remains unclear.
• The kinase domain of RIP2 is not essential for TNF-induced NF-kappaB activation or cell death.

Purpose of the Study:

• To investigate the function of the RIP2 kinase domain.
• To elucidate the role of RIP2 in activating signaling pathways beyond NF-kappaB.
• To identify novel catalytic functions of RIP-like kinases in the TNF receptor superfamily.

Main Methods:

• Investigated RIP2's role in activating the extracellular signal-regulated kinase (ERK) pathway.
• Utilized in vivo and in vitro assays to demonstrate direct phosphorylation and activation of ERK2 by RIP2.
• Examined the interaction of RIP2 with Ras-activated Raf1 and the effect of kinase-defective RIP2 variants on ERK2 activation.

Main Results:

• RIP2 activates the ERK pathway, with its kinase activity being crucial for this process.
• RIP2 phosphorylates and activates ERK2 both in vivo and in vitro.
• RIP2-mediated ERK activation is dependent on its interaction with Raf1 and is triggered by TNFalpha but not epidermal growth factor.

Conclusions:

• This study identifies a novel pathway for ERK activation mediated by RIP2.
• The findings ascribe the first catalytic function to a RIP-like kinase associated with the TNF receptor superfamily.
• RIP2's kinase activity is essential for activating the ERK pathway, revealing a new role for this kinase.